(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 11.43% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Inspire Medical Systems's revenue in 2025 is $861,312,000.On average, 8 Wall Street analysts forecast INSP's revenue for 2025 to be $26,754,227,524, with the lowest INSP revenue forecast at $26,676,033,032, and the highest INSP revenue forecast at $26,850,521,496. On average, 9 Wall Street analysts forecast INSP's revenue for 2026 to be $30,774,146,000, with the lowest INSP revenue forecast at $29,846,399,707, and the highest INSP revenue forecast at $33,179,425,120.
In 2027, INSP is forecast to generate $35,379,340,190 in revenue, with the lowest revenue forecast at $33,617,124,997 and the highest revenue forecast at $38,760,098,550.